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Decreased Coronary Flow Reserve in Hypertrophic
Cardiomyopathy Is Related to Remodeling of the
Coronary Microcirculation
R. Krams, MD, PhD; M.J.M. Kofflard, MD; D.J. Duncker, MD, PhD; C. Von Birgelen, MD;
S. Carlier, MD; M. Kliffen, MD, PhD; F.J. ten Cate, MD, PhD; P.W. Serruys, MD, PhD
Background—Ischemia occurs frequently in hypertrophic cardiomyopathy (HCM) without evidence of epicardial stenosis.
This study evaluates the hypothesis that the occurrence of ischemia in HCM is related to remodeling of the
coronary microcirculation.
Methods and Results—End-diastolic septal wall thickness was significantly increased in patients with HCM (25.862.9 mm)
in comparison with cardiac transplant recipients (control subjects: 11.463.0 mm; P,0.05). Although the diameter of the
left anterior descending coronary artery was similar in both groups (3.060.8 versus 3.060.5 mm, P5NS), the coronary
resistance reserve (CRR5CRRbasal/CRRhyperemic), corrected for extravascular compression (end-diastolic left ventricular
pressure), was reduced to 1.560.6 in HCM (P,.05; control, 2.660.8). Arteriolar lumen (AL) divided by wall area was
lower in HCM (2165% versus 3064%; P,.05), and capillary density tended to decrease (from 18246424 to 14456513
per mm2, P5.11) in HCM. CRR was linearly related to normalized AL according to the formula CRR50.1 AL20.45
(r5.57; P,.05). Further analysis revealed that CRR, AL, and capillary density were all linearly related to the degree of
hypertrophy.
Conclusions—Decrements in CRR were related to changes of the coronary microcirculation. Both the decrease in CRR and
these changes in the coronary microcirculation were related to the degree of hypertrophy. All these factors might
contribute to the well-known occurrence of ischemia in this patient group. (Circulation. 1998;97:230-233.)
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Anginal symptoms and signs of ischemia occur frequently inpatients with HCM without detectable lesions of the
major epicardial arteries,1–5 suggesting that the presence of
ischemia is the result of abnormalities of the coronary micro-
circulation. Indeed, postmortem analysis of HCM hearts
showed the existence of arterioles with abnormally thick
walls.6,7 Furthermore, in experimentally induced hypertrophy,
it has been shown that the hypertrophic process is accompa-
nied not only by decrements in CFR but also by structural
changes in the coronary microcirculation (coronary remodel-
ing), including a decreased capillary density.8–10 The resulting
increased diffusion distances for oxygen and the disturbed
perfusion of the capillary bed have been forwarded as an
explanation for ischemia.8–10
Although the CFR is decreased in HCM, in accordance
with the findings of experimentally induced hypertrophy,9,10 it
is unknown at present whether the decreased CFR is related to
the abnormal arterioles and whether a decrease in capillary
density accompanies this decrease in AL. To that end, we
measured CFR in combination with a quantitative analysis of
AL, wall area and capillary density in myocardial tissue ob-




Studies were performed in a group of patients with hypertrophic
obstructive cardiomyopathy (HCM; n510) who were referred for
cardiac catheterization. The control group consisted of asymptomatic
cardiac transplant recipients (HTx group; n58) undergoing follow-up
coronary angiography after transplantation. Informed consent was
obtained from all patients. Patients in the HCM group were symp-
tomatic (NYHA class II or III) despite b-blockade therapy (n55) or
therapy with calcium antagonists (n55). These patients were consid-
ered candidates for surgery (myotomy/myectomy). Medical therapy
was continued in both groups. Right heart catheterization was
performed with a 7F balloon-tipped flow-directed thermodilution
catheter. A 7F temporary pacemaker was positioned into the right
atrium. Left heart catheterization was carried out, after which left
ventricular angiography and coronary arteriography were performed
with standard techniques. A 0.014-in Doppler guidewire with a floppy
distal end (Cardiometrics, Inc) was introduced through an 8F guiding
catheter and positioned at the midsegment of the LAD to measure
Doppler flow velocity at rest and after hyperemia. In both groups,
hearts were paced at a constant heart rate of 100 bpm to avoid
metabolic vasodilatation during determination of the CFR. After
optimization of the settings of the velocity signal and 3 to 5 minutes
after intracoronary injection of a bolus of 2 to 3 mg isosorbide
dinitrate, baseline recordings of flow velocity and perfusion pressure
were collected and digitized at a sample rate of 125 Hz for off-line
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analysis. Maximal hyperemia was induced by an intracoronary bolus
injection of 18 mg adenosine.10
Doppler Measurements
The sample volume of the Doppler wire was positioned at a distance
of 5.2 mm from the transducer and was '2.25 mm wide. After power
spectral analysis based on a fast Fourier transform algorithm, the
maximal Doppler shift (kHz) was automatically tracked and converted
to the instantaneous velocity values (cm/s). CFR was defined as
hyperemic divided by basal velocity (Vcor). Coronary resistance was
defined as (Pao2Ped)/Vcor, where Pao is aortic pressure and Ped is end
diastolic pressure. Ped was subtracted to account for increments in
extravascular compression. CRR was defined as the ratio of basal
divided by hyperemic resistance.
Quantitative Angiographic Measurements
A validated on-line analysis system operating on digital images
(ACA-DCI, Philips11) was used during the catheterization procedure.
With this system, the end-diastolic diameter of the LAD was deter-
mined in the segment of the LAD in which the sample volume of the
Doppler wire was located.
Echocardiographic Measurements
Two-dimensional echocardiographic studies were performed (HP
Sonos 1500) with the heart being visualized from standard cross-
sectional planes while images were recorded on videotape (VHS) for
off-line analysis. Septal wall thickness was measured in diastole from
both the parasternal short-axis and long-axis views. From the record-
ings on videotape, representative stop-frames from the various cross-
sectional planes were acquired to determine septal wall thickness with
the aid of a computer and a dedicated software program. To obtain an
average for septal wall thickness, the various cross-sectional planes
were pooled. One patient from the control group was not analyzed
because of insufficient image quality. Thickness of the septal wall for
the HCM and the control groups was defined as the degree of
hypertrophy.
Histological Measurements
The myocardial tissues from the HCM group (n59) and from the
control group (n58) were obtained from surgical myectomy (left
ventricular septal tissue; weight, 0.3 to 1 g) and myocardial biopsies
(left ventricular septal tissue; weight, 0.5 to 1 mg), respectively.
During catheterization, one HCM patient presented without a subval-
vular pressure gradient and was not operated on. The tissue was fixed
with paraldehyde and immersed in 10% buffered formalin. van Gieson
staining was used for identification and analysis of intramyocardial
small arteries. Arterioles were identified on the basis of the appearance
of a layer of media and diameter ,100 mm. Only arterioles with
round cross sections and without side branches were analyzed.
Capillaries were identified with specific antibodies (CD34) against
endothelium. Quantitative morphometric analysis of the histological
sections occurred with an in-house–developed software program
applied to a morphometric system (Clemex Technology Inc) that
calculated density of capillaries (capillaries per square millimeter),
taking tissue shrinkage into account. Five cross sections per patient
('1000 capillaries) were analyzed. In addition, software was available
that allowed us to trace the arteriolar lumen-intima and adventitia-
media borders, which defined the lumen and wall thickness regions.
The areas of these regions were obtained from the number of pixels in
the two regions. Normalized wall area is given by circular wall
area/(lumen area1wall area). This value was calculated for 10 arte-
rioles per patient. Data are presented as mean6SD. Regression
analysis, ANOVA, and t tests were performed with standard statistical
software (SPSS). A value of P,.05 was considered significant.
Results
The HTx recipients, who served as control subjects, had no
cardiac complaints, and all of them had normal coronary
arteriograms. The time interval of catheterization after trans-
plantation was 462 years. Medication of HTx patients at the
time of catheterization was immunosuppression (n58) Ca21
antagonists (n58), aspirin (n55), and dipyridamole (n54). No
member of the control group had signs of rejection on the basis
of the biopsies. Age distributions between the HCM
(45.5614.6 years) and control (48.766.0 years) groups were
similar. HCM patients were symptomatic (NYHA class II or
III), whereas all members of the control group were symptom
free (NYHA class I). HCM patients had a subvalvular gradient
of 88631 mm Hg and a lower aortic pressure (103614 versus
120615 mm Hg, P,.05), a higher end-diastolic left ventric-
ular pressure (2261 versus 1266 mm Hg, P,.05), a lower
cardiac index (2.760.5 versus 3.560.7 L/m2, P,.05), and a
lower heart rate during baseline conditions (70613 versus
97613 bpm, P,.05) than the control group.
End-diastolic septal wall thickness was significantly increased
in patients with HCM (25.862.9 mm) compared with mem-
bers of the control group (11.463.0 mm; P,.05). All HCM
patients had normal angiograms. The diameter of the LAD was
similar in both groups (3.060.8 versus 3.060.5 mm). Coro-
nary velocity during baseline conditions was higher for HCM
patients (34611 versus 20611 cm/s, P,.05), whereas veloc-
ities during hyperemia were similar (49620 versus 53622
cm/s). As a consequence, the CFR was reduced from 2.660.8
in the control group to 1.860.9 in the HCM group (P,.05).
Coronary resistance values, corrected for extravascular com-
pression (see above), were lower (3.762.1 versus 6.562.2
mm Hg z s z cm21, P,.05) during baseline conditions and were
similar during hyperemia (2.661.5 versus 2.661.0, P5NS) in
HCM. Consequently, the CRR was lower (1.560.6 versus
2.660.8, P,.05) in HCM than in the control group. Arte-
riolar wall area was similar (572062130 versus
710763544 mm2; P5NS), but lumen area (12736688 versus
226061165 mm2; P,.05) and diameters were significantly
lower (19.664.5 versus 25.964.3 mm; P,.05) in HCM
compared with control values. Consequently, AL was lower in
the HCM (2165%) than in the control group (3064%;
P,.05), and capillary density tended to decrease from
18246424 to 14456513 per square millimeter in HCM
(P5.11). In addition, both the CFR and the CRR were
linearly related to AL according to the formula CFR50.1
AL20.45 (r5.57; P,.05) and CRR50.07 AL10.35 (r5.50;
P,.05; Fig 1A). Further analysis revealed that the degree of AL
(AL520.85 Hyp143.7; r5.71; P,.05; Fig 1B), the CFR
(CFR520.17 Hyp15.9; r5.80; P,.05), the CRR
(CRR521.2 Hyp14.7; r5.7; P,.05; Fig 1C), and the
capillary density (CD5251 Hyp12750; r5.53; P,.05; Fig
1D) were all inversely related to the degree of hypertrophy
(Hyp). In addition, a linear relationship between AL and
Selected Abbreviations and Acronyms
AL 5 normalized arteriolar lumen
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capillary density was measured (AL542 CD1577; r5.54;
P,.05).
Discussion
In symptomatic patients with HCM without evidence of a
functional stenosis of the epicardial vessels, decrements in
CFR were detected, confirming earlier studies.1–5 Similar
decrements in CRR were measured, implying that these
findings could not be explained by increments in extravas-
cular compression.9,10 Abnormal arterioles with decreased
lumen were detected in HCM patients, suggesting that a
structural change in the coronary arterial vascular tree might
be related to this finding. Indeed, a positive relationship
between both CFR and CRR and AL, corrected for tissue
shrinkage by normalization to the wall area,7 was detected.
Furthermore, an inverse relationship was noted between AL
and the degree of hypertrophy, confirming earlier postmor-
tem studies.7 Because of this relationship, an inverse rela-
tionship between CFR and the degree of hypertrophy could
be measured. Again, a similar relationship was found be-
tween CRR and degree of hypertrophy, implying that
extravascular compressive forces were not essential for these
findings. In large-animal models of pressure overload–
induced left ventricular hypertrophy, vascular medial hy-
pertrophy has been observed only when the coronary
circulation was exposed to high perfusion pressures. The
present arteriolar abnormalities were obtained at normal to
low aortic pressures and might imply that hypertrophy of
the arterioles, in parallel to the hypertrophy of the myocar-
dium, is an independent process.7
A decreased capillary density has been measured in several
animal studies with experimentally induced secondary hyper-
trophy and recently in humans with secondary hypertro-
phy.12,13 Although differences between the groups in capillary
density did not reach levels of statistical significance, there
clearly was an inverse relationship between capillary density
and degree of hypertrophy. Furthermore, the decrements in
capillary density and decrements of AL are related in HCM.
These findings may imply that the decreased AL induces
periods of ischemia, which results in increased angiogenesis.
This angiogenesis normalizes the decrements in capillary den-
sity. However, because we did not analyze HCM myocardial
tissue without hypertrophy, we cannot exclude the possibility
that the occurrence of changes in the coronary microcircula-
tion in HCM is a more independent phenomenon and not
directly related to the degree of hypertrophy.6,7
Relationship of CRR with AL (A), AL and degree of hypertrophy (B), CRR and degree of hypertrophy (C), and capillary density and
degree of hypertrophy (D).
232 Microcirculation in HCM
In conclusion, septal hypertrophy is associated with decre-
ments in CFR and CRR in HCM patients. Arterioles of
HCM patients exhibited a smaller lumen at similar wall
thickness, which correlated well with decrements in CFR and
CRR. These findings suggest that abnormal arterioles might
contribute to the perfusion abnormalities found in these
patients, resulting in recurrent myocardial ischemia.
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